加拿大局限性前列腺癌队列中2014年Gleason分级分组的优化
结果显示GG1-5的5年治疗失败率分别为9.6%、23.5%、43.1%、52.6%和84.3%,五级系统预测准确性优于四级系统(Harrell一致性指数0.716 vs 0.676),进一步调整后可达0.730。
要点
- GG1-5的5年治疗失败率分别为9.6%、23.5%、43.1%、52.6%和84.3%。
- GG2/3伴三级Gleason 5模式者失败率更高,类似GG3/4无三级模式者。
- GG5中原发Gleason模式4/5的5年失败率分别为82.3%和97.1%。
核心结论
- 五级GG系统较既往分级系统提高了治疗失败预测准确性,但仍可进一步优化。
研究设计与样本
- 手术标本由泌尿生殖病理学家按2014年ISUP标准评估,治疗失败定义为生化复发和/或开始辅助以外的二线治疗。
- 采用Kaplan-Meier法、log-rank检验、Cox比例风险模型和Harrell一致性指数进行分析。
主要发现
- GG1-5的5年治疗失败率分别为9.6%、23.5%、43.1%、52.6%和84.3%(GG2与GG3比较P<0.001)。
- GG2和GG3中伴三级Gleason 5模式的患者治疗失败率高于同组无三级模式者(P<0.001),但与GG3或GG4无三级模式者相似(P>0.3)。
- GG5中原发Gleason模式4/5预测治疗失败,5年失败率分别为82.3%和97.1%(P=0.001)。
- 五级GG系统作为预后指标的准确性高于四级系统(Harrell一致性指数0.716 vs 0.676)。
- 将GG2/3伴三级Gleason 5模式者上调至GG3/4,并按原发Gleason模式区分GG5后,Harrell一致性指数增至0.730。
临床怎么用
- 在局限性前列腺癌根治术后评估中,可采用2014年ISUP五级GG系统进行预后分层。
- 对GG2/3伴三级Gleason 5模式者,可考虑按更高一级GG进行风险分层。
- 对GG5患者,可结合原发Gleason模式(4 vs 5)进一步区分治疗失败风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the five-tier Gleason grade group (GG) scoring of prostate cancers adopted by the International Society of Urology Pathology (ISUP) in 2014, and to propose modifications to optimize its performance. PATIENTS AND METHODS: Data were obtained from PROCURE, a prospective cohort of patients with localized prostate cancer undergoing radical prostatectomy in Québec, 2006-2013. Surgical specimens were evaluated by genitourinary pathologists using 2014 ISUP criteria. Treatment failure was defined as biochemical recurrence and/or initiation of secondary, non-adjuvant therapy. Analyses were conducted using Kaplan-Meier methods, log-rank tests, Cox proportional hazards models and Harrell's concordance indices. RESULTS: A total of 1 917 patients were included, with a median follow-up of 69 months. The 5-year treatment failure rates were 9.6%, 23.5%, 43.1%, 52.6% and 84.3% in GG1-5, respectively (P < 0.001 when comparing GG2 with GG3). Treatment failure rates for patients in GG2 and GG3 with tertiary Gleason 5 pattern were higher than patients in the same group without a tertiary pattern (P < 0.001), but were similar to rates for patients in GGs 3 or 4 without a tertiary pattern (P > 0.3). Primary Gleason pattern (4/5) predicted treatment failure in GG5 (5-year failure rates 82.3% vs 97.1%, respectively; P = 0.001). The five-tier GG system had greater accuracy as a prognostic indicator compared with the four-tier system (Harrell's concordance index 0.716 vs 0.676). When upgrading patients in GG2/3 with tertiary Gleason 5 pattern to patients in GG3/4, and separating patients in GG5 by primary Gleason pattern, the Harrell's concordance index increased to 0.730. CONCLUSION: The five-tier GG system increased accuracy for predicting treatment failure compared with the previous grading systems, but can be further improved.
引用
- Wissing M, Brimo F, Chevalier S, et al. Optimization of the 2014 Gleason grade grouping in a Canadian cohort of patients with localized prostate cancer. BJU Int. 2018. PMID: 30113732. doi:10.1111/bju.14512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。